Home » Topics » BioWorld Science

BioWorld Science
RSS

Narrower interferon activity could benefit immune therapy

April 22, 2020

Modeling the post-infarct heart

April 22, 2020

Depression's structural problem

April 22, 2020

Phase III VANISH-306 study of oral ibrexafungerp in VVC meets primary endpoint

April 21, 2020

Cara reports topline data from KALM-2 trial of Korsuva in hemodialysis patients with pruritus

April 21, 2020

IMDC recommends continuation of phase III trial of eryaspase in advanced pancreatic cancer

April 21, 2020

Nucorion begins first-in-human study of NCO-48 fumarate for hepatitis B

April 21, 2020

New nitric oxide production inhibitors presented by FronThera US Pharmaceuticals

April 21, 2020

Cardurion Pharmaceuticals synthesizes new CAMK2 inhibitors

April 21, 2020

Genzyme identifies new GALC inhibitors

April 21, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.